HI
BPMC

Harbour Investments’s Blueprint Medicines BPMC Stock Holding History

Harbour Investments’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$25.6K – 3762
2025
Q2 		$25.6K Hold
200
– – ﹤0.01% 2121
2025
Q1 		$17.7K Hold
200
– – ﹤0.01% 2241
2024
Q4 		$17.4K Hold
200
– – ﹤0.01% 2187
2024
Q3 		$18.5K Hold
200
– – ﹤0.01% 2094
2024
Q2 		$21.6K Hold
200
– – ﹤0.01% 1926
2024
Q1 		$19K Hold
200
– – ﹤0.01% 1979
2023
Q4 		$18.4K Hold
200
– – ﹤0.01% 1906
2023
Q3 		$10K Hold
200
– – ﹤0.01% 2032
2023
Q2 		$12.6K Hold
200
– – ﹤0.01% 1940
2023
Q1 		$9K Hold
200
– – ﹤0.01% 2054
2022
Q4 		$8.76K Hold
200
– – ﹤0.01% 2008
2022
Q3 		$10K Hold
200
– – ﹤0.01% 1916
2022
Q2 		$10K Buy
+200
New +$11.7K ﹤0.01% 1916
2021
Q4 		$21K Sell
200
-27
-12% -$2.82K ﹤0.01% 1642
2021
Q3 		$23K Buy
227
+11
+5% +$1.02K ﹤0.01% 2213
2021
Q2 		$19K Hold
216
– – ﹤0.01% 2366
2021
Q1 		$21K Buy
+216
New +$21.6K ﹤0.01% 2172

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Harbour Investments's BPMC Position: Q3 2025 in Review

Harbour Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 200 shares — an estimated $25.6K sold.

Harbour Investments first reported a position in BPMC in Q1 2021 and held it in 17 quarters. The position peaked at $25.6K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Harbour Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Harbour Investments sold 200 Blueprint Medicines shares in Q3 2025, an estimated $25.6K.
  • Harbour Investments first reported a position in Blueprint Medicines in Q1 2021 and held it in 17 quarters.
  • Harbour Investments's Blueprint Medicines position peaked at $25.6K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Harbour Investments's 13F filing for Q3 2025, filed 12 Nov 2025.